Cargando…
Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients
BACKGROUND: Low-dose methotrexate (MTX) is the first-line therapy in early rheumatoid arthritis (eRA). Up to 40% of eRA patients do not benefit from MTX therapy. MTX has been shown to inhibit one-carbon metabolism, which is involved in the donation of methyl groups. In this study, we investigate bas...
Autores principales: | Gosselt, Helen R., van Zelst, Bertrand D., de Rotte, Maurits C. F. J., Hazes, Johanna M. W., de Jonge, Robert, Heil, Sandra G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595617/ https://www.ncbi.nlm.nih.gov/pubmed/31242943 http://dx.doi.org/10.1186/s13075-019-1936-5 |
Ejemplares similares
-
Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures
por: Gosselt, Helen R., et al.
Publicado: (2020) -
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis
por: Gosselt, Helen R., et al.
Publicado: (2021) -
Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients
por: Gosselt, Helen R., et al.
Publicado: (2021) -
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
por: Gosselt, Helen R., et al.
Publicado: (2020) -
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
por: Emery, Paul, et al.
Publicado: (2020)